JPH0160471B2 - - Google Patents
Info
- Publication number
- JPH0160471B2 JPH0160471B2 JP942680A JP942680A JPH0160471B2 JP H0160471 B2 JPH0160471 B2 JP H0160471B2 JP 942680 A JP942680 A JP 942680A JP 942680 A JP942680 A JP 942680A JP H0160471 B2 JPH0160471 B2 JP H0160471B2
- Authority
- JP
- Japan
- Prior art keywords
- camptothecin
- present
- choline salt
- choline
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims description 23
- 229940127093 camptothecin Drugs 0.000 claims description 23
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims description 23
- -1 Camptothecin choline salt Chemical class 0.000 claims description 15
- 239000004381 Choline salt Substances 0.000 claims description 15
- 235000019417 choline salt Nutrition 0.000 claims description 15
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000759905 Camptotheca acuminata Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP942680A JPS56108787A (en) | 1980-01-31 | 1980-01-31 | Camptothecin coline salt and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP942680A JPS56108787A (en) | 1980-01-31 | 1980-01-31 | Camptothecin coline salt and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56108787A JPS56108787A (en) | 1981-08-28 |
| JPH0160471B2 true JPH0160471B2 (ko) | 1989-12-22 |
Family
ID=11720006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP942680A Granted JPS56108787A (en) | 1980-01-31 | 1980-01-31 | Camptothecin coline salt and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS56108787A (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8622541D0 (en) * | 1986-09-18 | 1986-10-22 | Trondex Ltd | Producing mouldings |
| US5527913A (en) * | 1993-02-25 | 1996-06-18 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
| US5352789A (en) * | 1993-02-25 | 1994-10-04 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
| US6407118B1 (en) | 1996-01-30 | 2002-06-18 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
| US6096336A (en) * | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| US5731316A (en) | 1996-01-30 | 1998-03-24 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
| US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
| US7041650B2 (en) * | 2001-07-09 | 2006-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivative salts |
| NZ601684A (en) | 2010-02-10 | 2013-08-30 | Kissei Pharmaceutical | Salt of fused heterocyclic derivative and crystal thereof |
-
1980
- 1980-01-31 JP JP942680A patent/JPS56108787A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56108787A (en) | 1981-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH01186893A (ja) | 水溶性カンプトテシン類似体 | |
| CA2370692C (en) | Antitumor derivative of double dicarboxylic acid diaminoplatin complex, process for the preparing thereof, the pharmaceutical composition containing the same and application of the derivative | |
| US5041578A (en) | Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents | |
| JPH0160471B2 (ko) | ||
| KR910009823B1 (ko) | 백금착물(白金錯物) | |
| WO2001076569A2 (en) | An improved pt(iv) antitumor agent | |
| CN111423438B (zh) | 具有抗肿瘤活性的Eudistomins Y类衍生物及其制备方法和应用 | |
| CA1308653C (en) | Antihepatopathic composition containing protoporphyrin 1x-zn (11) complex | |
| CN1040591A (zh) | 铂-(iv)-二胺复合物、制备该类化合物的方法、至少含有一个铂化合物的具有抗肿瘤作用的制剂，以及具有抗肿瘤作用的成型制剂 | |
| CA2005851A1 (en) | Platinum complex | |
| CN100441177C (zh) | 环淫羊藿甙元作为制备防治器官移植排斥反应药物的应用 | |
| CN113024557A (zh) | 一种Peganumine A生物碱结构简化物及其应用 | |
| SE436208B (sv) | Sett att framstella 5-fluoro-uracilderivat | |
| JPH0460472B2 (ko) | ||
| JPH0329800B2 (ko) | ||
| JPH04264092A (ja) | シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途 | |
| CA2366048A1 (en) | Water soluble transplatinum complexes with anti-cancer activity and method of using same | |
| JPS61210032A (ja) | 抗腫瘍剤 | |
| SU1586520A3 (ru) | Способ получени N-нитрозо-N-(бета-хлорэтил)карбамоилпептидов или их солей | |
| US2753340A (en) | Maleate salts of protoveratrine a and protoveratrine b | |
| JPH0742287B2 (ja) | ２−アミノアルキル−９−ヒドロキシエリプテイシニウム誘導体のクロライドの塩酸塩及びそれを含む医薬 | |
| EP0214862A2 (en) | Anti-tumour platinum complexes, their preparation and their use | |
| EP0310260A2 (en) | Platinum complexes and their use as anti-tumor agents | |
| JPS645597B2 (ko) | ||
| Eckhardt et al. | The pharmacology of methane sulfonyl choline |